| SARS-CoV-2 productively infects human gut enterocytes MM Lamers, J Beumer, J van der Vaart, K Knoops, J Puschhof, ... Science 369 (6499), 50-54, 2020 | 1704 | 2020 |
| Severe acute respiratory syndrome coronavirus 2− specific antibody responses in coronavirus disease patients NMA Okba, MA Müller, W Li, C Wang, CH GeurtsvanKessel, VM Corman, ... Emerging infectious diseases 26 (7), 1478, 2020 | 1616 | 2020 |
| Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model B Rockx, T Kuiken, S Herfst, T Bestebroer, MM Lamers, BB Oude Munnink, ... Science 368 (6494), 1012-1015, 2020 | 1006 | 2020 |
| Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19) JJA van Kampen, DAMC van de Vijver, PLA Fraaij, BL Haagmans, ... Nature communications 12 (1), 267, 2021 | 670 | 2021 |
| SARS-CoV-2 pathogenesis MM Lamers, BL Haagmans Nature reviews microbiology 20 (5), 270-284, 2022 | 579 | 2022 |
| SARS-CoV-2 is transmitted via contact and via the air between ferrets M Richard, A Kok, D de Meulder, TM Bestebroer, MM Lamers, NMA Okba, ... Nature communications 11 (1), 3496, 2020 | 486 | 2020 |
| Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients CH GeurtsvanKessel, D Geers, KS Schmitz, AZ Mykytyn, MM Lamers, ... Science immunology 7 (69), eabo2202, 2022 | 369 | 2022 |
| Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants JJA van Kampen, DAMC van de Vijver, PLA Fraaij, BL Haagmans, ... MedRxiv, 2020.06. 08.20125310, 2020 | 249 | 2020 |
| SARS-CoV-2 specific antibody responses in COVID-19 patients NMA Okba, MA Müller, W Li, C Wang, CH GeurtsvanKessel, VM Corman, ... MedRxiv, 2020.03. 18.20038059, 2020 | 235 | 2020 |
| Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014 VS Raj, EABA Farag, CBEM Reusken, MM Lamers, SD Pas, J Voermans, ... Emerging infectious diseases 20 (8), 1339, 2014 | 232 | 2014 |
| An organoid‐derived bronchioalveolar model for SARS‐CoV‐2 infection of human alveolar type II‐like cells MM Lamers, J van Der Vaart, K Knoops, S Riesebosch, TI Breugem, ... The EMBO journal 40 (5), e105912, 2021 | 188 | 2021 |
| SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination P Li, Y Wang, M Lavrijsen, MM Lamers, AC de Vries, RJ Rottier, MJ Bruno, ... Cell research 32 (3), 322-324, 2022 | 179 | 2022 |
| Flaviviruses exploit the lipid droplet protein AUP1 to trigger lipophagy and drive virus production J Zhang, Y Lan, MY Li, MM Lamers, M Fusade-Boyer, E Klemm, C Thiele, ... Cell host & microbe 23 (6), 819-831. e5, 2018 | 171 | 2018 |
| ADAR1:“editor-in-chief” of cytoplasmic innate immunity MM Lamers, BG Van den Hoogen, BL Haagmans Frontiers in immunology 10, 453024, 2019 | 157 | 2019 |
| Susceptibility of rabbits to SARS-CoV-2 AZ Mykytyn, MM Lamers, NMA Okba, TI Breugem, D Schipper, ... Emerging Microbes & Infections 10 (1), 1-7, 2021 | 142 | 2021 |
| SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site AZ Mykytyn, TI Breugem, S Riesebosch, D Schipper, PB van den Doel, ... Elife 10, e64508, 2021 | 129 | 2021 |
| Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals LM Zaeck, MM Lamers, BE Verstrepen, TM Bestebroer, ME Van Royen, ... Nature medicine 29 (1), 270-278, 2023 | 128 | 2023 |
| Antigenic cartography of SARS-CoV-2 reveals that Omicron BA. 1 and BA. 2 are antigenically distinct AZ Mykytyn, M Rissmann, A Kok, ME Rosu, D Schipper, TI Breugem, ... Science Immunology 7 (75), eabq4450, 2022 | 95 | 2022 |
| Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation MM Lamers, AZ Mykytyn, TI Breugem, Y Wang, DC Wu, S Riesebosch, ... Elife 10, e66815, 2021 | 90 | 2021 |
| SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters F Armando, G Beythien, FK Kaiser, L Allnoch, L Heydemann, M Rosiak, ... Nature communications 13 (1), 3519, 2022 | 83 | 2022 |
Bart L. HaagmansDepartment of Viroscience, Erasmus MC, RotterdamVerified email at erasmusmc.nl
